Introduction
Methods
Results
Cohort | Country | Baseline years | Follow-up (years) | Study population | N (% women) | Age range (years) | N of diabetes (% women) | Type of diabetes | Ascertainment of diabetes | N of outcome (% women) | Fatal or non-fatal | Maximum adjustment available |
---|---|---|---|---|---|---|---|---|---|---|---|---|
APCSC [16] a | Pool of 32 cohorts | 1966–1999 | 7 | Population-based, occupational settings | 543,694 (36) | ≥20 | NA | Both | Self-reported, measured | 496 (NA) | F | Age, SBP, BMI, cigarette smoking, regression dilution bias, study (stratified) |
Policardo et al [23] b | Italy | 2008 | 5 | Population-based | 3,192,203 (NA) | ≥16 | 152,954 (NA) | Both | Prescription, exemption from paying for diabetes, hospitalisation with diagnosis of diabetes | 26,154 (55) | Both | Age, CCI, previous hospitalisations for other CVD |
KPMCP [26] | US | 1978–1984 | 9.5 median | Health maintenance organisation | 64,877 (54) | ≥40 | NA | Both | Self-reported, measured | 1330 (46) | Both | Age, race, education, HT, MI, frequent chest pain, TC, BMI, creatinine, uric acid, urine protein, LVH, smoking, alcohol c |
LRPP [25] | US, pool of 4 cohorts | 1948, 1971, 1987–1989, 1967–1973 | 27.1, 20.3 (for index aged 45 and 55) | Population-based | 19,249 (50), 23,915 (53) (for index aged 45 and 55) | 30–62, 5–70, 45–64, ≥18 | 659 (46), 1792 (52) (for index aged 45 and 55) | Both | Measured, treatment | 1677 (47), 2976 (52) (for index aged 45 and 55) | Both | Age, race, education, smoking status, HT, obesity |
CHS [24] | US | 1989–1990, 1992–1993 | 12.5 median | Population-based | 4817 (61) | ≥65 | 681 (53) | Both | Measured, treatment | 1342 (57) | Both | Age, clinical site, education, smoking, alcohol consumption, BMI, physical activity |
Swedish NDR (T1) [27] | Sweden | 1998–2011 | T1: 7.9, control: 8.3 | Population-based (T1 was identified through NDR) | T1: 33,402 (45), control: 166,228 (45) | ≥18 | 33,402 (45) | T1 | NDR | 2387 (39) | Both | Age, time-updated diabetes duration, birth in Sweden, educational level, baseline comorbidities |
Swedish NDR (T2) [20] | Sweden | 1998–2012 | 5.6 median | Population-based (T2 was identified through NDR) | T2: 266,305 (45), control: 1,323,504 (45) | T2: 62, control: 62 mean | 266,305 (45) | T2 | NDR | T2: 18,715 (46), control: 50,157 (45) | Both | Age, duration of diabetes, income, education, marital status, immigration status, stroke, acute MI, CHD, AF, renal dialysis or transplantation |
Kaiser Permanente Georgia [17] | US | 2000–2005 | 2.8 | Health maintenance organisation | 359,947 (53) | ≥18 | 12,344 (49) | Both | Medical record, pharmacy claim | 4001 (50) | Both | Age, HT, coronary artery disease, AF, valvular heart disease |
NHANES I Epidemiologic Follow-up Study [15] | US | 1971–1975 | 19 | Population-based | 13,643 (59) | 25–74 | 521 (61) | Both | Self-reported | 1382 (46) | Both | Age, race, education, physical activity, smoking, alcohol consumption, overweight, HT, valvular heart disease, CHD, BMI, SBP, TC, hypercholesterolaemia |
Taiwan’s NHI system [19] | Taiwan | 2000 | T2: 7.8, control: 8.0 | Population-based | T2: 34,291 (47), control: 34,291 (47) | 60 mean | 34,291 (47) | T2 | Ambulatory care claims | 8420 (51) | Both | Age, geographical area, urbanisation status, Hx of CHD, Hx of coronary revascularisation procedures, statins, β-blockers, diuretics |
Saskatchewan Health databases [22] | Canada | 1991–1996 | 5.2 | Population-based | T2 11,881 (45), control: 552,765 (51) | ≥30 | 11,881 (45) | T2 | Prescription | 2263 (46) | Both | Age |
CALIBER programme [5] | UK | 1998–2010 | 5.5 median | Primary care practices | 1,921,260 (51) | ≥30 | 34,198 (46) | T2 | Medical record | 13,938 (NA) | Both | Age, BMI, deprivation, HDL-C, TC, SBP, smoking, statin and antihypertensive drug prescriptions |
Ballotari et al [21] | Italy | 2011 | 3 | Population-based | 356,191 (51) | 30–84 | 24,348 (44) | T2 | Diabetes register | 2321 (44) | Both | Age, foreign status d |
NHS Information Services Scotland [18] | UK | 2004–2013 | 10 | Population-based | T1: 18,240 (45), T2 136,042 (46), no diabetes 3,066,253 (54) | ≥30 | T1: 18,240 (45), T2: 136,042 (46) | T1, T2 | Diabetes register | T1: 1313 (NA), T2: 22,959 (NA), no diabetes: 91,429 (NA) | Both | Age, socioeconomic status, calendar year e |